| Schedule of (Loss) Income Before Income Taxes and Related Expense (Benefit) |
The (loss) income before income taxes and the related expense are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Years Ended March 31, | | | 2026 | | 2025 | | 2024 | | (Loss) income before income taxes: | | | | | | | Bermuda(1) | | $ | 62,366 | | | $ | (80,590) | | | $ | 5,189,812 | | | United States | | (354,509) | | | (174,763) | | | (232,592) | | | Switzerland | | 21,711 | | | (426,478) | | | (389,948) | | | Other | | 5,854 | | | 241 | | | 584 | | | Total (loss) income from continuing operations before income taxes | | $ | (264,578) | | | $ | (681,590) | | | $ | 4,567,856 | |
(1)Primarily entities which are centrally managed and controlled in the U.K. and are subject to U.K. taxes.
|
| Schedule of Reconciliation of Income Tax Expense |
A reconciliation of income tax expense computed at the Bermuda statutory rate to income tax expense reflected in the consolidated financial statements for the year ended March 31, 2026, pursuant to the new disclosure requirements of ASU 2023-09, is as follows (in thousands, except percentages): | | | | | | | | | | | | | | | | Year Ended March 31, 2026 | | Income tax benefit at Bermuda statutory tax rate (1) | $ | — | | | — | % | | | Foreign Tax Effects | | | United Kingdom | | | Statutory tax rate difference between Bermuda and U.K. | $ | 16,177 | | | (6.1) | % | | | Nondeductible/(nontaxable) changes in the fair value of investments and loss from equity method investments | (27,488) | | | 10.4 | % | | | Taxable intercompany income/(deductible intercompany expense) | (123,074) | | | 46.5 | % | | | Nontaxable income | (16,606) | | | 6.3 | % | | | Nondeductible changes in the fair value of the Earn-Out Shares | 11,926 | | | (4.5 | %) | | | Valuation allowance | 142,562 | | | (53.9) | % | | | Other | (3,524) | | | 1.3 | % | | | Switzerland | | | Statutory tax rate difference between Bermuda and Switzerland | 2,086 | | | (0.8) | % | | Cantonal and communal taxes (2) | 39,289 | | | (14.8) | % | | | Deductible federal taxes | (13,590) | | | 5.1 | % | | | Intercompany reorganization | 138,465 | | | (52.3) | % | | | Valuation allowance | (112,256) | | | 42.4 | % | | Reversal of certain deferred tax assets(3) | 25,351 | | | (9.6) | % | | | Other | 544 | | | (0.2) | % | | | United States | | | Statutory tax rate difference between Bermuda and the U.S. | (74,930) | | | 28.3 | % | | | Nondeductible executive compensation | 60,323 | | | (22.8) | % | | | Tax deficiencies (excess tax benefits) from stock-based compensation | (34,482) | | | 13.0 | % | | | Taxable intercompany income/ (deductible intercompany expense) | 160,909 | | | (60.8) | % | | | Foreign-derived intangible income | (26,310) | | | 9.9 | % | | | Income/(loss) from disregarded entities | (64,511) | | | 24.4 | % | | | Research tax credits | (20,336) | | | 7.7 | % | | | Valuation allowance | 44,916 | | | (17.0) | % | | | Other | 7,888 | | | (2.9) | % | | | Total income tax expense | $ | 133,329 | | | (50.4) | % | |
(1)The Company’s country of domicile is Bermuda, as we are legally incorporated there, and therefore have applied its 0% statutory rate. (2)The taxes in Swiss canton of Basel-Stadt made up the majority of the state tax effect in this category (greater than 50%) (3)Primarily relates to deferred tax assets associated with entities no longer included in the consolidated financial statements (i.e. sold, deconsolidated, or liquidated) and Switzerland expiring net operating losses. A reconciliation of income tax expense computed at the Bermuda statutory rate to income tax expense reflected in the consolidated financial statements, for the years ending March 31, 2025 and 2024, are as follows (in thousands, except percentages): | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended March 31, 2025 | | Year Ended March 31, 2024 | Income tax expense at Bermuda statutory tax rate | $ | — | | | — | % | | $ | — | | | — | % | Foreign rate differential(1) | (112,413) | | | 16.5 | % | | 1,196,877 | | | 26.2 | % | | Permanent disallowed IPR&D | — | | | — | % | | — | | | — | % | | Tax effect of changes in the fair value of investments and loss from equity method investments | (12,813) | | | 1.9 | % | | 15,431 | | | 0.3 | % | | Substantial shareholding exemption | (27,597) | | | 4.0 | % | | (1,337,102) | | | (29.3) | % | | Nondeductible executive compensation | 54,558 | | | (8.0) | % | | 19,727 | | | 0.4 | % | | Tax deficiencies (excess tax benefits) from stock-based compensation | (16,676) | | | 2.4 | % | | (21,668) | | | (0.5) | % | | Other permanent adjustments | 37,096 | | | (5.4) | % | | 40,085 | | | 0.9 | % | | Research tax credits | (31,840) | | | 4.7 | % | | (22,863) | | | (0.5) | % | | Valuation allowance | 134,855 | | | (19.8) | % | | 43,754 | | | 1.0 | % | Reversal of certain deferred tax assets(2) | 25,062 | | | (3.7) | % | | 87,262 | | | 2.0 | % | | Other | (2,058) | | | 0.3 | % | | — | | | — | % | | Total income tax expense | $ | 48,174 | | | (7.1) | % | | $ | 21,503 | | | 0.5 | % |
(1)Primarily related to operations in the U.S., Switzerland, the U.K., and other jurisdictions with statutory tax rates different than the Bermuda rate. (2)Primarily relates to deferred tax assets associated with entities no longer included in the consolidated financial statements (i.e., sold, deconsolidated or liquidated) and Switzerland expiring net operating losses.
|
| Schedule of Components of Deferred Tax Assets (Liabilities) |
Significant components of the deferred tax assets (liabilities) at March 31, 2026 and 2025 are as follows (in thousands): | | | | | | | | | | | | | March 31, 2026 | | March 31, 2025 | | Deferred tax assets | | | | | Research tax credits | $ | 76,810 | | | $ | 54,101 | | | Intangible assets | 8,732 | | | 16,939 | | | Capitalized research and development | 189,355 | | | 41,387 | | | Net operating loss | 550,011 | | | 469,339 | | | Share-based compensation | 35,167 | | | 103,515 | | | Lease liabilities | 22,622 | | | 21,687 | | | Other assets | 33,870 | | | 18,001 | | | Subtotal | 916,567 | | | 724,969 | | | Valuation allowance | (897,209) | | | (701,219) | | | | | | | Deferred tax liabilities | | | | | Depreciation | (2,593) | | | (561) | | | Right-of-use assets | (15,848) | | | (19,270) | | | Other liabilities | (917) | | | (3,919) | | | Total deferred tax assets/(liabilities) | $ | — | | | $ | — | |
|